HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ha-Ri Kim Selected Research

Acetylcholine (Acetylcholine Chloride)

10/2021Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ha-Ri Kim Research Topics

Disease

2Cognitive Dysfunction
11/2021 - 10/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2023
1Brain Diseases (Brain Disorder)
01/2023
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2023
1Amnesia (Dissociative Amnesia)
10/2021
1Deglutition Disorders (Dysphagia)
09/2020
1Stroke (Strokes)
09/2020
1Dehydration (Water Stress)
09/2020
1Aspiration Pneumonia
09/2020

Drug/Important Bio-Agent (IBA)

3guibi-tangIBA
01/2023 - 10/2021
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2023
1gamma-Aminobutyric Acid (GABA)IBA
11/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2021
1Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
10/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
10/2021
1Drinking WaterIBA
09/2020

Therapy/Procedure

1Therapeutics
01/2023
1Electroacupuncture
09/2020
1Length of Stay
09/2020